Brief: Quanterix To Participate In The 15th Clinical Trials On Alzheimer's Disease Task Force
16/11/2022 22:42
Nov 16 (Reuters) - Quanterix Corp QTRX.O :
* QUANTERIX TO PARTICIPATE IN THE 15TH CLINICAL TRIALS ON
ALZHEIMER’S DISEASE (CTAD) TASK FORCE
Source text for Eikon: ID:nBwq8h74a
Further company coverage: QTRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview